Charlotte Taylor
Articles
Sanofi Targets Tuberculosis Treatments
July 8th 2011Sanofi has entered into a research collaboration with the Weill Cornell Medical College in New York to develop new anti-infectives that aim to both shorten the course of treatment for tuberculosis and provide effective therapies against drug-susceptible and drug-resistant strains of the disease.
Latest Updated Articles
Published: January 10th 2025 | Updated: January 13th 2025
Cavazzoni Retires as CDER Director
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: January 10th 2025 | Updated: January 13th 2025
Cavazzoni Retires as CDER Director
Published: January 2nd 2025 | Updated: January 15th 2025
London Biotechnology Show: June 18–19, 2025
Published: December 10th 2024 | Updated: January 15th 2025
Breaking barriers: EnzeneX™ to EnzeneX™ 2.0
